SUCLG2 and cancer: In pan-cancer, we found that SMOX was most highly expressed in C5 and closely associated with resting NK cells, while SUCLG2 was most highly expressed in C3 and associated with T follicular helper cells, resting dendritic cells, activated NK cells, regulatory T cells, resting memory CD4 T cells, and monocytes.